Loading…

Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country

To identify laboratory biomarkers that predict disease severity and outcome among COVID-19 patients admitted to the Millennium COVID-19 Care Center in Ethiopia. A retrospective cohort study was conducted among 429 COVID-19 patients who were on follow up from July to October 2020. Data was described...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2021-03, Vol.16 (3), p.e0246087-e0246087
Main Authors: Leulseged, Tigist W, Hassen, Ishmael S, Ayele, Birhanu T, Tsegay, Yakob G, Abebe, Daniel S, Edo, Mesay G, Maru, Endalkachew H, Zewde, Wuletaw C, Naylor, Lydia K, Semane, Dejene F, Dresse, Menayit T, Tezera, Bereket B
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To identify laboratory biomarkers that predict disease severity and outcome among COVID-19 patients admitted to the Millennium COVID-19 Care Center in Ethiopia. A retrospective cohort study was conducted among 429 COVID-19 patients who were on follow up from July to October 2020. Data was described using frequency tables. Robust Poisson regression model was used to identify predictors of COVID-19 severity where adjusted relative risk (ARR), P-value and 95 CI for ARR were used to test significance. Binary Logistic regression model was used to assess the presence of statistically significant association between the explanatory variables and COVID-19 outcome where adjusted odds ratio (AOR), P-value and 95%CI for AOR were used for testing significance. Among the 429 patients studied, 182 (42.4%) had Severe disease at admission and the rest 247 (57.6%) had Non-severe disease. Regarding disease outcome, 45 (10.5%) died and 384 (89.5%) were discharged alive. Age group (ARR = 1.779, 95%CI = 1.405-2.252, p-value
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0246087